ACTRN12605000762651
Not yet recruiting
Not Applicable
Optimising glycaemic control in paediatric patients on insulin pump therapy: impact of glycaemic load and bolus wave type on postprandial glycaemia
Royal Children's Hospital, Parkville, Vic 3052.0 sites36 target enrollmentNovember 24, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 1 Diabetes Mellitus
- Sponsor
- Royal Children's Hospital, Parkville, Vic 3052.
- Enrollment
- 36
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prepubertal children specifically targeted to eliminate potential confounding effects of counter\-regulatory hormones of puberty.2\. Type 1 diabetes \> 1 year duration; active patients of RCH diabetes clinic3\. Established use of insulin pump therapy (using short acting analog insulin) for \> 3 months4\. Insulin pump with incorporated meal bolus calculator device (capable of delivering both single and dual wave boluses)5\. HbA1C \< 8\.6% HbA1C empirically chosen as cut\-off for 'acceptable' baseline glycaemic control \- corresponds to the mean HbA1C for all paediatric centres participating in the international Hvidore diabetes study group
Exclusion Criteria
- •1\. Non\-English speaking2\. Diagnosed eating disorder3\. Concomitant dietary restriction (eg food allergy)4\. Use of any other medication that may lower blood glucose5\. Free of diabetes\-related complications (microvascular disease, hypothyroidism, coeliac disease).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). - The CHIP TrialEUCTR2006-005715-10-GBRoyal Brompton & Harefield NHS Trust1,500
Completed
Not Applicable
Control of hyperglycaemia in paediatric intensive careHyperglycaemiaSigns and SymptomsElevated blood glucose levelISRCTN61735247Royal Brompton & Harefiled NHS Trust (UK)1,500
Active, not recruiting
Not Applicable
Optimizing of blood sugar control for surgical patients with diabetes type 2.Diabetes type 2.MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2013-002936-26-DKChristoffer Hedetoft
Recruiting
Not Applicable
Glycaemic control in patients with type 2 diabetes and colorectal- or breast cancer treated with curative intentType 2 diabetes (T2DM)Breast cancer/borstkankerColorectal cancer/colorectale kankerHypertension/hypertensieDyslipidemia/dyslipidemieNL-OMON23282Diabetes Kenniscentrum Zwolle156
Completed
Phase 4
To study the impact of age-patient-related, treatment-related, behavior and structure of care-related variables on glycemic control and quality of life in children, adolescents and young adults with type-1 diabetes mellitusHealth Condition 1: null- Type 1 Diabetes MellitusHealth Condition 2: E109- Type 1 diabetes mellitus without complicationsCTRI/2012/08/002925Sanofi Synthelabo India Limited5,000